Skip to main navigation Skip to search Skip to main content

A Randomized, Double-Blind, Phase 3 Study Evaluating the Safety and Efficacy of Venetoclaxin Combination with Azacitidine in Patients Newly Diagnosed with Higher-Risk Myelodysplastic Syndrome (Higher-Risk MDS)

Project: Research

Project Details

StatusActive
Effective start/end date09/1/20 → 09/30/26

Funding

  • AbbVie Incorporated: $37,284.56